New Opportunities in Non-Preservative Glaucoma Therapy
Most of the medicines used for the treatment of glaucoma include a preservative in various concentrations. With long-term topical therapy, patients with glaucoma may develop dry eye syndrome (DES). The severity of symptoms depends on the number of drugs used and the presence of a preservative in the...
Saved in:
| Main Authors: | A. A. Antonov, I. V. Kozlova, A. A. Vitkov |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2021-07-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1542 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Evaluation of the Efficacy and Safety of Brimonidine Generics in Glaucoma Therapy
by: A. A. Antonov, et al.
Published: (2023-12-01) -
Impact of combination of local carbonic anhydrase inhibitors and beta-blockers on intraocular pressure, visual functions and eye hemodynamics in primary open-angle glaucoma
by: T. N. Malishevskaya, et al.
Published: (2021-06-01) -
To the question about rational choice between original and generic drugs: arguments to use the first
by: N. S. Khodzhaev, et al.
Published: (2019-06-01) -
Efficacy and safety of 0.1 % brimonidine as a starting monotherapy and when added to combination therapy of glaucoma
by: E. D. Semenov, et al.
Published: (2024-12-01) -
Antioxidant activity of dorzolamide/timolol fixed combination in neuroprotective therapy in glaucoma
by: N. I. Kurysheva, et al.
Published: (2014-07-01)